On January 4, 2021, Intco Medical Technology Co., Ltd. closed the transaction. The company obtained the confirmation of the acceptance of share registration application issued by China Securities Depository and Clearing Co., Ltd. Shenzhen Branch. After the issuance, Liu Fangyi owns 141,068,874 shares in the company, accounting for 40.10% stake. Prior to the issuance, Liu Fangyi held 82,435,560 shares in the company, accounting for 37.08% stake. The company paid issue fees of CNY 4,167,373.12 including CNY 2,830,188.68 for sponsorship and underwriting fee, CNY 566,037.73 for audit and verification fee, CNY 754,716.96 for legal fees, and CNY 16,429.75 for issuance registration fee and other fees and received net proceeds of CNY 495,832,608.02.